annual operating expenses:
$177.38M+$127.03M(+252.34%)Summary
- As of today (September 18, 2025), CDTX annual total operating expenses is $177.38 million, with the most recent change of +$127.03 million (+252.34%) on December 31, 2024.
- During the last 3 years, CDTX annual operating expenses has risen by +$85.55 million (+93.16%).
- CDTX annual operating expenses is now at all-time high.
Performance
CDTX Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$27.38M+$2.12M(+8.37%)Summary
- As of today (September 18, 2025), CDTX quarterly total operating expenses is $27.38 million, with the most recent change of +$2.12 million (+8.37%) on June 30, 2025.
- Over the past year, CDTX quarterly operating expenses has increased by +$15.98 million (+140.15%).
- CDTX quarterly operating expenses is now -49.46% below its all-time high of $54.18 million, reached on December 31, 2024.
Performance
CDTX quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CDTX Operating expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +252.3% | +140.2% |
3 y3 years | +93.2% | +41.7% |
5 y5 years | +183.2% | +26.8% |
CDTX Operating expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +252.3% | -49.5% | +187.8% |
5 y | 5-year | at high | +252.3% | -49.5% | +187.8% |
alltime | all time | at high | >+9999.0% | -49.5% | +4798.8% |
CDTX Operating expenses History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $27.38M(+8.4%) |
Mar 2025 | - | $25.27M(-53.4%) |
Dec 2024 | $177.38M(+252.3%) | $54.18M(+211.5%) |
Sep 2024 | - | $17.39M(+52.5%) |
Jun 2024 | - | $11.40M(+19.8%) |
Mar 2024 | - | $9.52M(-17.0%) |
Dec 2023 | $50.34M(-48.6%) | $11.46M(-16.3%) |
Sep 2023 | - | $13.69M(+15.6%) |
Jun 2023 | - | $11.84M(-49.2%) |
Mar 2023 | - | $23.33M(-15.0%) |
Dec 2022 | $97.95M(+6.7%) | $27.43M(+6.2%) |
Sep 2022 | - | $25.82M(+33.6%) |
Jun 2022 | - | $19.33M(-23.8%) |
Mar 2022 | - | $25.37M(+5.7%) |
Dec 2021 | $91.83M(+9.4%) | $24.00M(-4.4%) |
Sep 2021 | - | $25.11M(+13.7%) |
Jun 2021 | - | $22.09M(+7.1%) |
Mar 2021 | - | $20.63M(-18.4%) |
Dec 2020 | $83.92M(+34.0%) | $25.28M(+26.7%) |
Sep 2020 | - | $19.95M(-7.7%) |
Jun 2020 | - | $21.60M(+26.4%) |
Mar 2020 | - | $17.09M(+7.5%) |
Dec 2019 | $62.64M | $15.89M(-1.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | $16.07M(+12.6%) |
Jun 2019 | - | $14.27M(-13.0%) |
Mar 2019 | - | $16.40M(-1.2%) |
Dec 2018 | $63.28M(+13.6%) | $16.60M(+12.7%) |
Sep 2018 | - | $14.72M(-2.8%) |
Jun 2018 | - | $15.15M(-9.9%) |
Mar 2018 | - | $16.81M(+24.9%) |
Dec 2017 | $55.72M(+15.0%) | $13.46M(+9.9%) |
Sep 2017 | - | $12.25M(-26.3%) |
Jun 2017 | - | $16.61M(+24.0%) |
Mar 2017 | - | $13.40M(-6.7%) |
Dec 2016 | $48.44M(+49.9%) | $14.35M(+16.4%) |
Sep 2016 | - | $12.34M(+4.0%) |
Jun 2016 | - | $11.86M(+20.0%) |
Mar 2016 | - | $9.88M(-0.4%) |
Dec 2015 | $32.31M(+222.6%) | $9.93M(+7.8%) |
Sep 2015 | - | $9.21M(+42.8%) |
Jun 2015 | - | $6.45M(-4.2%) |
Mar 2015 | - | $6.73M(+44.8%) |
Dec 2014 | $10.02M(+825.7%) | $4.65M(+40.0%) |
Sep 2014 | - | $3.32M(+123.1%) |
Jun 2014 | - | $1.49M(+166.2%) |
Mar 2014 | - | $559.00K |
Dec 2013 | $1.08M | - |
FAQ
- What is Cidara Therapeutics, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual operating expenses year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly operating expenses year-on-year change?
What is Cidara Therapeutics, Inc. annual total operating expenses?
The current annual operating expenses of CDTX is $177.38M
What is the all time high annual operating expenses for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual total operating expenses is $177.38M
What is Cidara Therapeutics, Inc. annual operating expenses year-on-year change?
Over the past year, CDTX annual total operating expenses has changed by +$127.03M (+252.34%)
What is Cidara Therapeutics, Inc. quarterly total operating expenses?
The current quarterly operating expenses of CDTX is $27.38M
What is the all time high quarterly operating expenses for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly total operating expenses is $54.18M
What is Cidara Therapeutics, Inc. quarterly operating expenses year-on-year change?
Over the past year, CDTX quarterly total operating expenses has changed by +$15.98M (+140.15%)